Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Fox

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Biochemical Society Transactions|August 1, 1997
Nitric oxide and oxygen metabolismG C Brown, A G McBride, E J Fox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1984
Cellular requirements for induction of human primary proliferative responses to trinitrophenyl-modified cellsM F Brown, M Van, S L Abramson, et al.
Anesthesiology|December 1, 1977
Complications related to the pressor response to endotracheal intubationE J Fox, G S Sklar, C H Hill, et al.
Ear and Hearing|June 1, 1986
Central vestibular findings on electronystagmographyR L Steenerson, S M Van de Water, W H Sytsma, et al.
OTJR : Occupation, Participation and Health|June 29, 2023
Perceptions of Autonomous Shuttles for Adults With Spinal Cord InjuriesJustin Mason, C Hanson, E J Fox, et al.
The Journal of Experimental Medicine|August 1, 1987
T suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytesE J Fox, D E Lewis, K P Deemer, et al.
Physical Review Letters|May 23, 2015
Precise Quantization of the Anomalous Hall Effect near Zero Magnetic FieldA J Bestwick, E J Fox, Xufeng Kou, et al.
European Journal of Neurology|September 9, 2011
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosisE J Fox, H C Sullivan, S K Gazda, et al.
Human Pathology|July 1, 1996
Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formationL A Teot, R J O'Keefe, R N Rosier, et al.
Journal of Neurology|October 19, 2010
Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative studyG Anderson, D Meyer, C E Herrman, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Biochemical Society Transactions|August 1, 1997
Nitric oxide and oxygen metabolismG C Brown, A G McBride, E J Fox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1984
Cellular requirements for induction of human primary proliferative responses to trinitrophenyl-modified cellsM F Brown, M Van, S L Abramson, et al.
Anesthesiology|December 1, 1977
Complications related to the pressor response to endotracheal intubationE J Fox, G S Sklar, C H Hill, et al.
Ear and Hearing|June 1, 1986
Central vestibular findings on electronystagmographyR L Steenerson, S M Van de Water, W H Sytsma, et al.
OTJR : Occupation, Participation and Health|June 29, 2023
Perceptions of Autonomous Shuttles for Adults With Spinal Cord InjuriesJustin Mason, C Hanson, E J Fox, et al.
The Journal of Experimental Medicine|August 1, 1987
T suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytesE J Fox, D E Lewis, K P Deemer, et al.
Physical Review Letters|May 23, 2015
Precise Quantization of the Anomalous Hall Effect near Zero Magnetic FieldA J Bestwick, E J Fox, Xufeng Kou, et al.
European Journal of Neurology|September 9, 2011
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosisE J Fox, H C Sullivan, S K Gazda, et al.
Human Pathology|July 1, 1996
Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formationL A Teot, R J O'Keefe, R N Rosier, et al.
Journal of Neurology|October 19, 2010
Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative studyG Anderson, D Meyer, C E Herrman, et al.
Pageof 4